Breast Cancer Disparities Among Women in Low- and Middle-Income Countries

被引：30
作者：
Ginsburg O. [1 ]
Rositch A.F. [2 ]
Conteh L. [3 ]
Mutebi M. [4 ]
Paskett E.D. [5 ]
Subramanian S. [6 ,7 ]
机构：
[1] Perlmutter Cancer Center and Section for Global Health, Department of Population Health, NYU Langone Health, New York, NY
[2] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
[3] School of Public Health, Imperial College London, London
[4] Aga Khan University, Nairobi
[5] Ohio State University, Columbus, OH
[6] RTI International, Waltham, MA
[7] International Agency for Research on Cancer, Lyon
来源：
Current Breast Cancer Reports | 2018年 / 10卷 / 3期
基金：
英国医学研究理事会;
关键词：
Breast cancer; Cancer disparities; Cost-effectiveness; Health economics; Health systems;
D O I：
10.1007/s12609-018-0286-7
中图分类号：
学科分类号：
摘要：
Purpose of Review: The burden of breast cancer in low-income and middle-income countries transitioning to higher levels of human development is a public health crisis, set to increase dramatically in the coming decades. This paper provides an overview of the burden in human and economic terms, a summary of the costs, and cost-effective analyses for breast cancer interventions and suggests a way forward through research to better inform national, regional, and global policies for breast cancer control. Recent Findings: Inequitable access to effective health services for breast cancer is striking between and within countries, where much of the costs are shouldered through out-of-pocket expenditures. A variety of factors can influence opportunities for women with breast symptoms to seek care and to access effective and affordable early detection and treatment services. Summary: Research into disparities and solutions to overcome these, including an evidence-informed investment case for breast cancer control, can help to garner the necessary political will and sustained commitments to ensure adequate and sustainable resources are available to reduce disparities in breast cancer survival. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：179 / 186
页数：7
相关论文
共 75 条
  • [51] (2014)
  • [52] Sankaranarayanan R., Ramadas K., Thara S., Muwonge R., Prabhakar J., Augustine P., Venugopal M., Anju G., Mathew B.S., Clinical breast examination: preliminary results from a cluster randomized controlled trial in India, J Natl Cancer Inst, 103, 19, pp. 1476-1480, (2011)
  • [53] Pisani P., Parkin D.M., Ngelangel C., Esteban D., Gibson L., Munson M., Reyes M.G., Laudico A., Outcome of screening by clinical examination of the breast in a trial in the Philippines, Int J Cancer, 118, 1, pp. 149-154, (2006)
  • [54] Kardinah D., Anderson B.O., Duggan C., Ali I.A., Thomas D.B., Short report: limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia, Int J Cancer, 134, 5, pp. 1250-1255, (2014)
  • [55] Handbooks of Cancer Prevention Volume 15: Breast Cancer Screening International Agency for Research on Cancer, (2016)
  • [56] Best Buys and Other Recommendations for the Prevention and Control of Noncommunicable Diseases, (2017)
  • [57] Dvaladze A., Duggan C., Gralow J.R., Anderson B.O., Phased implementation model of resource-stratified guidelines for breast Cancer control, J Global Oncol, 3, (2017)
  • [58] Horton S., Gauvreau C.L., Cancer in low- and middle-income countries: an economic overview, Cancer: Disease Control Priorities, 3, (2015)
  • [59] Anderson B.O., Ilbawi A.M., El Saghir N.S., Breast cancer in low and middle income countries (LMICs): a shifting tide in global health, Breast J, 21, 1, pp. 111-118, (2015)
  • [60] Subramanian S., Gakunga R., Kibachio J., Gathecha G., Edwards P., Ogola E., Et al., Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors, PLoS One, (2018)
12345678